Recently, ligands of the prostate-specific membrane antigen (PSMA) have been introduced in positron emission tomography (PET) imaging of PCa, targeting an extracellular domain of this transmembraneous cell-surface protein [8, 9]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.